Jathin Bandari - 01 Jul 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Chief Medical Officer
Signature
/s/ Mary Grendell, Attorney-in-Fact
Issuer symbol
TARA
Transactions as of
01 Jul 2022
Net transactions value
-$2,196
Form type
4
Filing time
05 Jul 2022, 17:00:29 UTC
Previous filing
12 Jan 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability $2,196 -682 -3.2% $3.22 20,318 01 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 1, 2020.